BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 30292850)

  • 1. Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer Patients: Secondary Findings From the Prospective Randomized Phase 3 CONVERT Trial.
    Levy A; Le Péchoux C; Mistry H; Martel-Lafay I; Bezjak A; Lerouge D; Padovani L; Taylor P; Faivre-Finn C
    J Thorac Oncol; 2019 Feb; 14(2):294-297. PubMed ID: 30292850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational and design of prophylactic cranial irradiation (PCI) and brain MRI surveillance versus brain MRI surveillance alone in patients with limited-stage small cell lung cancer achieving complete remission (CR) of tumor after chemoradiotherapy: a multicenter prospective randomized study.
    Chen M; Li R; Kong Y; Shi L; Wang J; Wang Y; Xu Y; Ji Y; Hu X
    BMC Cancer; 2024 Apr; 24(1):429. PubMed ID: 38589800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Chemoradiotherapy With Outcomes Among Patients With Stage I to II vs Stage III Small Cell Lung Cancer: Secondary Analysis of a Randomized Clinical Trial.
    Salem A; Mistry H; Hatton M; Locke I; Monnet I; Blackhall F; Faivre-Finn C
    JAMA Oncol; 2019 Mar; 5(3):e185335. PubMed ID: 30520977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer.
    Chu X; Li S; Xia B; Chu L; Yang X; Ni J; Zou L; Li Y; Xie C; Lin J; Zhu Z
    Radiat Oncol; 2019 Sep; 14(1):171. PubMed ID: 31533763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-evaluation of prophylactic cranial irradiation in limited-stage small cell lung cancer: a propensity score matched analysis.
    Inoue Y; Tsujino K; Sulaiman NS; Marudai M; Kajihara A; Miyazaki S; Sekii S; Uezono H; Ota Y; Soejima T
    J Radiat Res; 2021 Sep; 62(5):877-883. PubMed ID: 34230962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment Response and Prophylactic Cranial Irradiation Are Prognostic Factors in a Real-life Limited-disease Small-cell Lung Cancer Patient Cohort Comprehensively Staged With Cranial Magnetic Resonance Imaging.
    Eze C; Roengvoraphoj O; Niyazi M; Hildebrandt G; Fietkau R; Belka C; Manapov F
    Clin Lung Cancer; 2017 Jul; 18(4):e243-e249. PubMed ID: 28065620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rates of Overall Survival and Intracranial Control in the Magnetic Resonance Imaging Era for Patients With Limited-Stage Small Cell Lung Cancer With and Without Prophylactic Cranial Irradiation.
    Pezzi TA; Fang P; Gjyshi O; Feng L; Liu S; Komaki R; Lin SH
    JAMA Netw Open; 2020 Apr; 3(4):e201929. PubMed ID: 32236532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Study of Hippocampal-Sparing Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer.
    Redmond KJ; Hales RK; Anderson-Keightly H; Zhou XC; Kummerlowe M; Sair HI; Duhon M; Kleinberg L; Rosner GL; Vannorsdall T
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):603-611. PubMed ID: 28581401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy.
    Winther-Larsen A; Hoffmann L; Moeller DS; Khalil AA; Knap MM
    Acta Oncol; 2015; 54(9):1574-81. PubMed ID: 26203924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of prophylactic cranial irradiation in patients with small cell lung cancer in the modern era of baseline magnetic resonance imaging of the brain.
    Held MK; Hansen O; Schytte T; Hansen KH; Bahij R; Nielsen M; Nielsen TB; Jeppesen SS
    Acta Oncol; 2022 Feb; 61(2):185-192. PubMed ID: 34583620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total gross tumor volume is an independent prognostic factor in patients treated with selective nodal irradiation for stage I to III small cell lung cancer.
    Reymen B; Van Loon J; van Baardwijk A; Wanders R; Borger J; Dingemans AM; Bootsma G; Pitz C; Lunde R; Geraedts W; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1319-24. PubMed ID: 23200174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival impact of prophylactic cranial irradiation in small-cell lung cancer in the modern era of magnetic resonance imaging staging.
    Lim YJ; Song C; Kim HJ; ;
    Radiat Oncol; 2022 Feb; 17(1):26. PubMed ID: 35123531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic cranial irradiation after definitive chemoradiotherapy for limited-stage small cell lung cancer: Do all patients benefit?
    Farooqi AS; Holliday EB; Allen PK; Wei X; Cox JD; Komaki R
    Radiother Oncol; 2017 Feb; 122(2):307-312. PubMed ID: 28073578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study protocol: watchful observation of patients with limited small cell lung cancer instead of the PCI-prospective, multi-center one-arm study.
    Nawrocki S; Sugajska A
    BMC Cancer; 2020 Mar; 20(1):231. PubMed ID: 32188425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic cranial irradiation for patients with limited-stage small-cell lung cancer with response to chemoradiation.
    Tai P; Assouline A; Joseph K; Stitt L; Yu E
    Clin Lung Cancer; 2013 Jan; 14(1):40-4. PubMed ID: 22673624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE).
    Salama JK; Gu L; Wang X; Pang HH; Bogart JA; Crawford J; Schild SE; Vokes EE; Ready NE
    J Thorac Oncol; 2016 Mar; 11(3):361-9. PubMed ID: 26723241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic cranial irradiation in small cell lung cancer: a systematic review and meta-analysis.
    Yin X; Yan D; Qiu M; Huang L; Yan SX
    BMC Cancer; 2019 Jan; 19(1):95. PubMed ID: 30665432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for brain metastasis in patients with small cell lung cancer without prophylactic cranial irradiation.
    Zheng Y; Wang L; Zhao W; Dou Y; Lv W; Yang H; Sun Y; Xing L
    Strahlenther Onkol; 2018 Dec; 194(12):1152-1162. PubMed ID: 30218136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study.
    Rodríguez de Dios N; Couñago F; Murcia-Mejía M; Rico-Oses M; Calvo-Crespo P; Samper P; Vallejo C; Luna J; Trueba I; Sotoca A; Cigarral C; Farré N; Manero RM; Durán X; Gispert JD; Sánchez-Benavides G; Rognoni T; Torrente M; Capellades J; Jiménez M; Cabada T; Blanco M; Alonso A; Martínez-San Millán J; Escribano J; González B; López-Guerra JL
    J Clin Oncol; 2021 Oct; 39(28):3118-3127. PubMed ID: 34379442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic cranial irradiation (PCI) versus active surveillance in patients with limited-stage small cell lung cancer: a retrospective, multicentre study.
    Chen Y; Wang Y; Ren F; Huang Z; Tan B; Zhao Z; Yu X; Dong P; Yu J; Meng X
    Respir Res; 2022 Oct; 23(1):274. PubMed ID: 36184624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.